US chemical company Chemours has opened its Chemours Battery Innovation Center (CBIC), a laboratory facility located at the company’s Discovery Hub in Newark, Delaware, US. A multi-million-dollar investment, the CBIC supports the testing and scaling of next generation battery technologies, to enable more sustainable, cost-effective, energy-efficient, and high-performing batteries for hybrid and electric vehicles (EVs), Chemours said.
US specialty chemicals and materials company Chemours has appointed Denise Dignam as the company’s permanent CEO and president, as well as a member of the board of directors, effective immediately.
3M has agreed to pay $10.3 billion to resolve legal challenges brought against the company by US public water systems over its discharges of polyfluoroalkyl substances (PFAS) into US waterways. The deal is subject to approval by a US federal court.
DuPont and former group units Chemours and Corteva have agreed to pay more than $1 billion to settle out of court US claims that per- and polyfluoroalkyl substances (PFAS) discharged from their plants contaminated waterways that supply a majority of US public water systems.
Chemours has agreed to sell its glycolic acid business to PureTech Scientific for $137 million cash. The transaction is expected to close by the third quarter of this year, subject to regulatory approval and other usual conditions.
The European Chemicals Agency (ECHA) is moving to advance the petition to restrict the use of poly-fluorinated alkyl substances (PFASs submitted in January by the environmental authorities of Denmark, Germany, the Netherlands, Norway and Sweden.
US specialty chemicals and materials company Chemours will spend $200 million to increase capacity for its Nafion ion exchange membranes at its site in Villers-Saint-Paul, France.
American Chemistry Council (ACC), the industry association representing US chemical producers, is suing the US Environmental Protection Agency (EPA) over its Lifetime Health Advisories (LHAs) for per-fluoroalkyl and poly-fluoroalkyl chemicals (PFAS).
Chemours is expanding capacity for its Opteon YF refrigerants to meet customer demand. The Delaware-headquartered US group described the $80 million project at Corpus Christi, Texas, as a “critical growth investment.”
Chemours, the former DuPont chemicals business, is looking at investing in additional ionomers capacity to support growing demand into water electrolysis and fuel cell technology. The company is currently considering potential locations in the US and Europe with, it said, an eye to local community engagement and collaboration.
Chemours has started a strategic review to assess the potential sale of its Mining Solutions business. The company has retained New York-based financial advisor Gordon Dyal & Co. to assist in the review.
US chemical company Chemours announced on Feb. 11 that it had split its Fluoroproducts segment into two distinct businesses during the fourth quarter of 2020.
DuPont, along with Chemours, its former fluourochemicals and plastics business, and Corteva, the combined agrochemicals businesses of DuPont and Dow, have buried the hatchet and announced a cost-sharing agreement worth $4 billion to settle lawsuits over liability for discharges into US waterways of perfluorinated compounds such as PFAS and PFOA.
